ERBB2 and neoplasm: Using these annotations of immune cell type and state, we performed a cell type diversity and differential abundance analysis to capture global and more granular changes in cell type composition within the TME with respect to clinical phenotypes such as tumor subtype (ER+, HER2+, TNBC).